News
Variantyx Licenses IBM Technologies That Leverage AI for Somatic Analysis
December 22, 2020 Variantyx, the leader in high complexity hereditary disease testing, today announced that it has entered into a…
Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders
March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding…
Whole-genome sequencing and health insurance
By Daryl Spinner, PhD, MBA In the realm of genetic testing, insurance payers have been reluctant to recognize that there…
Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market
January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®…
Ethics in Whole Genome Sequencing
By Toni Lewis The use of whole-genome sequencing (WGS) in diagnostic testing brings up the topic of secondary findings or…